Publications
2022
The transcription factor FoxP3 can fold into two dimerization states with divergent implications for regulatory T cell function and immune homeostasis.
Immunity. 55(8):1354-1369.e8Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells.
Immunity. 55(7):1173-1184.e7Hierarchical regulation of the resting and activated T cell epigenome by major transcription factor families.
Nat Immunol. 23(1):122-1342021
Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity.
Nat Immunol. 22(9):1163-1174A unified atlas of CD8 T cell dysfunctional states in cancer and infection.
Mol Cell. 81(11):2477-2493.e102020
FXR mediates T cell-intrinsic responses to reduced feeding during infection.
Proc Natl Acad Sci U S A. 117(52):33446-33454The Transcription Factor Foxp3 Shapes Regulatory T Cell Identity by Tuning the Activity of trans-Acting Intermediaries.
Immunity. 53(5):971-984.e52019
Natural Genetic Variation Reveals Key Features of Epigenetic and Transcriptional Memory in Virus-Specific CD8 T Cells.
Immunity. 50(5):1202-1217.e72016
Memory of Inflammation in Regulatory T Cells.
Cell. 166(4):977-9902015
Genetic and epigenetic variation in the lineage specification of regulatory T cells.
Elife. 4:e07571A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance.
Nature. 528(7580):132-136miR-182 is largely dispensable for adaptive immunity: lack of correlation between expression and function.
J Immunol. 194(6):2635-422014
Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells.
Nat Immunol. 15(6):580-587Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus.
Cell. 158(4):749-7632013
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Nature. 504(7480):451-5Transcriptional control of regulatory T-cell differentiation.
Cold Spring Harb Symp Quant Biol. 78:215-222012
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment.
J Control Release. 159(2):281-92010
Downregulation of EGFR by a novel multivalent nanobody-liposome platform.
J Control Release. 145(2):165-752009
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.
Curr Cancer Drug Targets. 9(6):748-60